# A Study of PSB205 in Subjects With Advanced Solid Tumors

> **NCT03986606** · PHASE1 · UNKNOWN · sponsor: **Qilu Puget Sound Biotherapeutics (dba Sound Biologics)** · enrollment: 64 (estimated)

## Conditions studied

- Neoplasm Malignant

## Interventions

- **BIOLOGICAL:** PSB205

## Key facts

- **NCT ID:** NCT03986606
- **Lead sponsor:** Qilu Puget Sound Biotherapeutics (dba Sound Biologics)
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-07-05
- **Primary completion:** 2021-02-28
- **Final completion:** 2021-07-28
- **Target enrollment:** 64 (ESTIMATED)
- **Last updated:** 2020-11-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03986606

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03986606, "A Study of PSB205 in Subjects With Advanced Solid Tumors". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03986606. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*